Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma [Phase 3]
Phase 3 clinical trial update on managing pain and chemotherapy-related symptoms in people with multiple myeloma or lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL [Phase 1]
Phase 1 trial evaluating haploidentical stem cell transplantation with prophylactic natural killer donor lymphocyte infusion in lymphoma, mu…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating atorvastatin for mitigating cardiotoxicity in acute myeloid leukemia; the study is not yet recruiting…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating the combination of Brentuximab Vedotin and Nivolumab in patients with early-stage classical Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: MargheRITA (Remote Intelligence for Therapeutic Adherence) [NA]
A completed clinical trial named MargheRITA (Remote Intelligence for Therapeutic Adherence) sponsored by Advice Pharma Group srl studied tre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Lung Screening in People Cured of Hodgkin Lymphoma [NA]
A completed clinical trial update evaluating lung cancer screening in individuals who have been cured of Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update on a Triplex CMV vaccine designed to prevent CMV infection in patients undergoing hematopoietic stem cell tran…
-
CLINICAL_TRIALS withdrawal · 2024-10-24Clinical Trial Update: Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas [Phase 1, Phase 2]
Clinical trial evaluating FE 203799 in adults with lymphomas has been withdrawn. The study examined safety, tolerability, and PK/PD in Phase…
-
CLINICAL_TRIALS withdrawal · 2024-10-22Clinical Trial Update: (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). [Phase 1]
Phase 1 pediatric lymphoma trial evaluating pediTACTAL TAA-specific cytotoxic T-lymphocytes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) [Phase 2]
Phase 2 trial of a cytomegalovirus vaccine for donors and recipients undergoing allogeneic hematopoietic cell transplantation has completed,…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL [Phase 2]
Phase 2 clinical trial evaluating nivolumab combined with ifosfamide, carboplatin, and etoposide as second-line therapy for recurrent or ref…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"
This Clinical Trial Update reports results from a Special Drug Use Surveillance study of Brentuximab Vedotin IV in relapsed or refractory CD…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) [Phase 3]
A Phase 3 clinical trial in Russia evaluating first-line chemotherapy for adults with classical Hodgkin lymphoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas [Phase 2]
Phase 2 trial evaluating brentuximab vedotin in relapsed or refractory EBV-positive, CD30-positive lymphomas; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
A completed study update based on a Spanish medical-record review of adults with relapsed or refractory CD30+ malignancies who were re-treat…
-
EMA approval · 2024-09-03EMA Authorised: Carmustine medac (previously Carmustine Obvius) (carmustine) — medac Gesellschaft für klinische Spezialpräparate mbH
EMA authorised Carmustine medac (carmustine) for Hodgkin lymphoma and non-Hodgkin lymphoma; the marketing authorization holder is medac Gese…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
A completed clinical trial evaluated blood markers of reproductive hormones to assess ovarian reserve in younger patients with newly diagnos…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating Brentuximab Vedotin versus the B-CAP regimen in older patients with newly diagnosed classical Hodgk…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating the combination of romidepsin and oral azacitidine in relapsed/refractory lymphoid malignancies, wit…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"
A clinical trial update reports completion and posting of results for a drug use surveillance study of Brentuximab vedotin in untreated CD30…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Relationship Between Serum β2-Microglobulin and Infiltration of CD8+ in the Tumor Tissue of Hodgkin's Lymphoma Patients
This completed clinical trial evaluated whether serum beta-2 microglobulin levels correlate with CD8+ T-cell infiltration in Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies [Phase 1]
Tinostamustine, a first-in-class alkylating HDAC inhibitor fusion molecule, completed its Phase 1 study in relapsed/refractory hematologic m…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders [Phase 1]
Phase 1 trial update on T-allo10 for hematopoietic stem cell transplantation in various blood disorders; the NCT03198234 study sponsored by …
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation
A completed observational study describing treatment patterns and disease control in participants with Hodgkin lymphoma and anaplastic large…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers [NA]
This clinical trial update indicates the study evaluating cardiac rehabilitation for patients receiving radiation therapy for thoracic cance…